Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Receivables - Net: 2023

Historic Receivables - Net for CG Oncology (CGON) over the last 1 years, with Dec 2023 value amounting to $92,000.

  • CG Oncology's Receivables - Net rose 275.91% to $515,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $515,000, marking a year-over-year increase of 275.91%. This contributed to the annual value of $92,000 for FY2023, which is N/A change from last year.
  • CG Oncology's Receivables - Net amounted to $92,000 in FY2023.
  • Over the past 5 years, CG Oncology's Receivables - Net peaked at $92,000 during FY2023, and registered a low of $92,000 during FY2023.
  • Its 1-year average for Receivables - Net is $92,000, with a median of $92,000 in 2023.